Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 10Completed 3Not yet recruiting 2Active not recruiting 2Terminated 1Suspended 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 41Breast Neoplasms 31Neoplasms 28Neoplasm Metastasis 23Melanoma 20Leukemia, Myeloid, Acute 20Prostatic Neoplasms 19Colorectal Neoplasms 17Multiple Myeloma 16Lung Neoplasms 16Recurrence 13Myelodysplastic Syndromes 13Squamous Cell Carcinoma of Head and Neck 12Lymphoma, Non-Hodgkin 12Carcinoma, Renal Cell 12Ovarian Neoplasms 11Lymphoma, Large B-Cell, Diffuse 11Carcinoma, Hepatocellular 11Urinary Bladder Neoplasms 10Uterine Cervical Neoplasms 9Pancreatic Neoplasms 9Glioblastoma 9Head and Neck Neoplasms 8Stomach Neoplasms 7Rectal Neoplasms 7Lymphoma, Follicular 7Glioma 7Brain Neoplasms 7Solid Tumor 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Digestive System Neoplasms × 90 days × Clear all
NCT05639153 2026-04-13

A Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of DR30303 in Patients With Advanced Solid Tumors

Zhejiang Doer Biologics Co., Ltd.

Phase 1 Terminated
13 enrolled
Gastrointestinal

Digestive System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡